AKT2 and idiopathic pulmonary fibrosis: This is consistent with results from Bibaki et al., which demonstrated that miR-29a, miR-185, and their targets Akt1 and Akt2, were involved in the development of idiopathic pulmonary fibrosis and lung cancer [53].